BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6178295)

  • 1. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas.
    Corson JM; Pinkus GS
    Am J Pathol; 1982 Jul; 108(1):80-8. PubMed ID: 6178295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratin in human lung tumors. Patterns of localization of different-molecular-weight keratin proteins.
    Said JW; Nash G; Banks-Schlegel S; Sassoon AF; Murakami S; Shintaku IP
    Am J Pathol; 1983 Oct; 113(1):27-32. PubMed ID: 6194690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.
    Holden J; Churg A
    Am J Surg Pathol; 1984 Apr; 8(4):277-9. PubMed ID: 6201076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
    Duggan MA; Masters CB; Alexander F
    Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen.
    Cibas ES; Corson JM; Pinkus GS
    Hum Pathol; 1987 Jan; 18(1):67-74. PubMed ID: 2434407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions.
    al-Saffar N; Hasleton PS
    Eur Respir J; 1990 Oct; 3(9):997-1001. PubMed ID: 1705232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
    Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE
    Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.
    Kawai T; Greenberg SD; Truong LD; Mattioli CA; Klima M; Titus JL
    Am J Pathol; 1988 Feb; 130(2):401-10. PubMed ID: 2449084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen and milk-fat globule protein staining of malignant mesothelioma and adenocarcinoma of the lung.
    Tron V; Wright JL; Churg A
    Arch Pathol Lab Med; 1987 Mar; 111(3):291-3. PubMed ID: 2435259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ultrastructural localization of keratin proteins and carcinoembryonic antigen in malignant mesotheliomas.
    Warhol MJ
    Am J Pathol; 1984 Sep; 116(3):385-90. PubMed ID: 6206729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive microvillous brush border staining with HBME-1 distinguishes pleural mesotheliomas from pulmonary adenocarcinomas.
    Dahlstrom JE; Maxwell LE; Brodie N; Zardawi IM; Jain S
    Pathology; 2001 Aug; 33(3):287-91. PubMed ID: 11523926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratins in malignant mesotheliomas and pleural adenocarcinomas: comparative immunohistochemical analysis with polyclonal and monoclonal antibodies.
    Bejui-Thivolet F; Patricot LM; Vauzelle JL; Viac J
    Pathol Res Pract; 1984 Sep; 179(1):67-73. PubMed ID: 6209691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
    Sheibani K; Battifora H; Burke JS
    Am J Pathol; 1986 May; 123(2):212-9. PubMed ID: 2422942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases.
    Chu PG; Weiss LM
    Mod Pathol; 2002 Jan; 15(1):6-10. PubMed ID: 11796835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological study of malignant diffuse mesotheliomas of the pleura.
    Loosli H; Hurlimann J
    Histopathology; 1984 Sep; 8(5):793-803. PubMed ID: 6083969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases.
    Otis CN; Carter D; Cole S; Battifora H
    Am J Surg Pathol; 1987 Jun; 11(6):445-56. PubMed ID: 2438954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratin and carcinoembryonic antigen in exfoliated mesothelial and malignant cells: an immunoperoxidase study.
    Walts AE; Said JW; Banks-Schlegel S
    Am J Clin Pathol; 1983 Nov; 80(5):671-6. PubMed ID: 6195913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.
    O'Hara CJ; Corson JM; Pinkus GS; Stahel RA
    Am J Pathol; 1990 Feb; 136(2):421-8. PubMed ID: 2305835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.